BMY 7378, soluble in DMSO, ethanol and water, inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets α1D-adrenoceptor, DopamineD2 receptor, α2-adrenoceptor, α2C-adrenoceptor, β1-adrenoceptor, β2-adrenoceptor, 5-HT1A, 5-HT1C, 5-HT1D, 5-HT2, and 5-HT3.
BMY 7378 can be used to modulate serotonin signaling pathways, potentially influencing conditions associated with serotonin dysfunction.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.